MoneyWorks4Me

Ajanta Pharma informs about disclosures

03 Jul 2026 Evaluate
Ajanta Pharma has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1856.40
Dr. Reddys Labs. 1171.75
Cipla 1374.85
Lupin 2090.50
Zydus Lifesciences 1129.35
View more..